Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma
Clinical trial NCT01851096 · COMPLETED
Trial details
- NCT number
- NCT01851096
- Sponsor
- Esanex Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-10-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.